Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Lingamneni Anila
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Simon, Christopher
Haemonetics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(10.65%)
Haemonetics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Neuberger Berman Group LLC(6.96%),Neuberger Berman Investment Advisers LLC(6.89%)
Haemonetics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Capital Research Global Investors(12.9%)
Haemonetics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(6.44%),Wellington Group Holdings LLP(6.44%), etc.
Haemonetics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(11.9%)
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Galvin Roy
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Basil Michelle L
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Strong Stewart W
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Miller Laurie A.
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Lingamneni Anila
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Strong Stewart W
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director Dockendorff Charles J
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director Bryant Diane M
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director Dockendorff Charles J
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director Zane Ellen M
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director Pomeroy Claire
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director KROLL MARK W
Haemonetics | 4: Statement of changes in beneficial ownership of securities-Director Johnson Lloyd Emerson
No Data